ZhuZhou QianJin Pharmaceutical Co.,Ltd
Symbol: 600479.SS
SHH
10.91
CNYDzisiejsza cena rynkowa
17.9517
Wskaźnik P/E
0.4616
Wskaźnik PEG
4.56B
Kapitalizacja MRK
- 0.03%
Rentowność DIV
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1997.9 | 1731.7 | 1369.7 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -45.7 | 491.7 | 736.8 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 967 | 983.9 | 921.6 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 534.1 | 599 | 547.8 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 15.4 | 198.9 | 78.1 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 3514.5 | 3513.5 | 2917.3 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 589.9 | 622.8 | 630.2 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 14.1 | 14.1 | 14.1 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 238.3 | 221.8 | 219.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 252.3 | 235.9 | 233.7 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 293.3 | -304.1 | -546.1 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 22.7 | 6.6 | 4.1 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 4.2 | 547.3 | 821 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1162.4 | 1108.5 | 1143 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 4676.9 | 4622 | 4060.2 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 647.5 | 780.9 | 511.7 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 78.2 | 79.5 | 88.6 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 70.6 | 72.5 | 35.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 38.5 | 44.8 | 60.3 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 38 | 44.4 | 51.3 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 69.1 | 705.6 | 75.5 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 108.3 | 108.5 | 131.9 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 31.5 | 32.8 | 44.8 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 1650.1 | 1805.7 | 1360.3 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 428.9 | 429.8 | 418.5 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 1142.5 | 970.8 | 930.7 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 280.8 | 275.3 | 298.1 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 537.5 | 540.3 | 503 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 2389.7 | 2216.2 | 2150.4 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4676.9 | 4622 | 4060.2 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 637.1 | 600.1 | 549.5 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 3026.8 | 2816.3 | 2699.9 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 247.6 | 187.6 | 190.8 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 116.7 | 124.2 | 148.9 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -1881.2 | -1115.7 | -484 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 395 | 388.3 | 374.7 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 103.7 | 95.6 | 85.9 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -2.8 | -3.6 | 2.7 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 2.8 | 3.6 | -2.7 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -81.7 | 246.9 | 65.8 | ||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -8.7 | -163.7 | 275.9 | ||||||||||||||||||||||
cash-flows.row.inventory | 0 | 62.3 | -51.2 | -52.4 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -132.5 | 465.4 | -160.4 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2.8 | -3.6 | 2.7 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 26.1 | 2.7 | -40.9 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -44 | -34.4 | -71.9 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.2 | 30.8 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -402 | -2102 | -1570 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1031.2 | 2258.4 | 1567.7 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0.1 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 585.3 | 122.1 | -43.3 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -50.7 | -15 | -127.6 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -147.9 | -248.6 | -429.5 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -13.1 | -0.5 | 36.5 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -202 | -264.2 | -520.6 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 826.4 | 591.4 | -78.3 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1928.3 | 1101.9 | 510.5 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1101.9 | 510.5 | 588.8 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 443.1 | 733.5 | 485.6 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -44 | -34.4 | -71.9 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 399.1 | 699 | 413.7 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3798.5 | 4026.3 | 3663.8 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 2046.7 | 2289.9 | 2032.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 1751.8 | 1736.4 | 1631.6 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -3337.9 | 218.6 | 189.1 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 3337.9 | 1311.7 | 1261.1 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3337.9 | 3601.5 | 3293.4 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 51.4 | 9.8 | 11.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1.7 | 2.2 | 2.1 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.5 | 1.6 | -2.8 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -3337.9 | 218.6 | 189.1 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.5 | 1.6 | -2.8 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1.7 | 2.2 | 2.1 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 103.7 | 104.2 | 47.3 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 460.6 | 444.2 | 436.2 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 459.1 | 445.8 | 433.4 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 65.4 | 57.6 | 58.7 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 320.4 | 302.5 | 302.1 |
Często zadawane pytania
Ile wynosi ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) aktywów ogółem?
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) całkowite aktywa to 4676882466.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.465.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 1.021.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.073.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.121.
Co to jest ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 320405834.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 116705915.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 3337921320.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.